患有肺部溢血与肺部的猫的耐火性充血性心力衰竭的时间
K M Buchanan1, R C Fries1, S Kadotani1
1Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, 1008 W Hazelwood Dr, Urbana, IL 61802, USA.
概括
与肺相比,患有充血性心力衰竭 (CHF) 的猫患上更短的存活时间和更快的进展到耐火性CHF.
科学领域:
- 兽医心脏病学
- 猫科动物医学
- 心血管研究
背景情况:
- 猫的左侧充血性心力衰竭 (CHF) 通常表现为肺部溢出或肺.
- 了解这些不同表现的预后影响对于猫类心脏护理至关重要.
研究的目的:
- 为了比较患有多发性肺溢血和肺的猫的耐火性心力衰竭 (CHF) 的时间和存活时间.
- 在被诊断患有各种心肌病的猫身上确定预后因素.
主要方法:
- 在2013年至2022年间诊断出患有CHF的125只猫的回顾性评估.
- 根据主要表现的情况对猫进行分类:肺部溢出 (n=73) 或肺 (n=52).
- 耐火性慢性心血管功能被定义为特定的富洛塞米德剂量或托塞米德启动;存活时间和耐火性慢性心血管功能的时间被记录下来.
主要成果:
- 与肺水腫患者 (234天) 相比,患有肺水腫的貓的平均存活時間顯著短 (155天).
- 患有肺部溢血的猫的中位时间也显著缩短 (44天),而不是肺部胀 (133天).
- 在多变量分析中,多流是短到耐火性心血管衰竭 (HR: 2.26) 和短到生存时间 (HR: 1.87) 的显著预测因素.
结论:
- 患有心脏不全症的猫流与预后较差,包括更短的存活时间和更快的进展到耐火性疾病.
- 这些发现凸显了对猫科冠状动脉炎的预后评估区分流和肺的重要性.
- 研究的局限性包括非标准化的治疗建议和不完整的液体分析数据.
相关概念视频
01:28Pleural Effusion II: Symptoms and Management
265
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
265
01:17Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
01:25Pleural Effusion I: Introduction
1.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.8K
01:26Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21